MVP — Medical Developments International Balance Sheet
0.000.00%
- AU$41.12m
- AU$21.42m
- AU$42.57m
Annual balance sheet for Medical Developments International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20.4 | 24.7 | 9.73 | 17.8 | 21.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.25 | 8.93 | 7.07 | 7.65 | 6.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 34.4 | 42.8 | 26.1 | 35.5 | 35.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.6 | 12.1 | 10.2 | 8.94 | 7.73 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 92.2 | 101 | 59.2 | 66.4 | 64.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.5 | 15.5 | 9.55 | 7.82 | 6.17 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 34.9 | 20 | 13.4 | 11.3 | 8.79 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 57.3 | 81.3 | 45.7 | 55.1 | 55.8 |
| Total Liabilities & Shareholders' Equity | 92.2 | 101 | 59.2 | 66.4 | 64.6 |
| Total Common Shares Outstanding |